Author Correction: Regorafenib is suitable for advanced colorectal cancer patients who have previously received trifluridine/tipiracil plus bevacizumab

Saved in:
Bibliographic Details
Published inScientific reports Vol. 13; no. 1; p. 11935
Main Authors Matsumoto, Toshihiko, Ikoma, Tatsuki, Yamamura, Shogo, Miura, Kou, Tsuduki, Takao, Watanabe, Takanori, Nagai, Hiroki, Takatani, Masahiro, Yasui, Hisateru
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 24.07.2023
Nature Publishing Group
Nature Portfolio
Subjects
Author
Author Correction
Colorectal carcinoma
Humanities and Social Sciences
multidisciplinary
Science
Science (multidisciplinary)
Online AccessGet full text

Cover

More Information
Bibliography:correction
SourceType-Other Sources-1
content type line 63
ObjectType-Correction/Retraction-1
ISSN:2045-2322
2045-2322
DOI:10.1038/s41598-023-39009-5